Ticiana Leal
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 45
- Lung Cancer Research Studies 27
- Colorectal Cancer Treatments and Studies 12
- Pancreatic and Hepatic Oncology Research 8
-
- Lung Cancer Treatments and Mutations 45
- Lung Cancer Diagnosis and Treatment 17
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
- Epidemiology top 5%
- Immunology top 10%
-
- Cancer therapeutics and mechanisms 13
- Co-authors
- Martin ReckJames G. ChristensenKaren VelasteguiDelvys Rodríguez‐AbreuMinal BarveSinéad CuffeJonathan W. RiessAli Tafreshi
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Ticiana Leal
86 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 1.5k
- Cancer Research 435
- Epidemiology 592
- Immunology 330
Countries citing papers authored by Ticiana Leal
This map shows the geographic impact of Ticiana Leal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ticiana Leal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ticiana Leal more than expected).
Fields of papers citing papers by Ticiana Leal
This network shows the impact of papers produced by Ticiana Leal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ticiana Leal. The network helps show where Ticiana Leal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ticiana Leal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 19 | |
| 16 | 2021 | 31 | |
| 17 | Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)breakdown → | 2021 | 484 |
| 18 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Studybreakdown → | 2021 | 165 |
| 19 | 2018 | 131 | |
| 20 | 2016 | 55 |
About Ticiana Leal
Ticiana Leal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 98 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Cancer Immunotherapy and Biomarkers (45 papers), Lung Cancer Research Studies (27 papers), Lung Cancer Diagnosis and Treatment (17 papers), Cancer therapeutics and mechanisms (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Genomics and Diagnostics (11 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Cancer Research (435 citations). Ticiana Leal has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Martin Reck, James G. Christensen, Karen Velastegui, Delvys Rodríguez‐Abreu, Minal Barve, Sinéad Cuffe, Jonathan W. Riess, Ali Tafreshi, Rina Hui and M. Catherine Pietanza. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.